Production of antibodies in SHuffle Escherichia coli strains.
Antibody
Disulfide bonds
E. coli
IgG
Oxidative protein folding
Recombinant protein expression
SHuffle
Journal
Methods in enzymology
ISSN: 1557-7988
Titre abrégé: Methods Enzymol
Pays: United States
ID NLM: 0212271
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
9
11
2021
pubmed:
10
11
2021
medline:
18
3
2022
Statut:
ppublish
Résumé
Antibodies are globally important macromolecules, used for research, diagnostics, and as therapeutics. The common mammalian antibody immunoglobulin G (IgG) is a complex glycosylated macromolecule, composed of two heavy chains and two light chains held together by multiple disulfide bonds. For this reason, IgG and related antibody fragments are usually produced through secretion from mammalian cell lines, such as Chinese Hamster Ovary cells. However, there is growing interest in production of antibodies in prokaryotic systems due to the potential for rapid and cheap production in a highly genetically manipulable system. Research on oxidative protein folding in prokaryotes has enabled engineering of Escherichia coli strains capable of producing IgG and other disulfide bonded proteins in the cytoplasm, known as SHuffle. In this protocol, we provide a review of research on prokaryotic antibody production, guidelines on cloning of antibody expression constructs, conditions for an initial expression and purification experiment, and parameters which may be optimized for increased purification yields. Last, we discuss the limitations of prokaryotic antibody production, and highlight potential future avenues for research on antibody expression and folding.
Identifiants
pubmed: 34752282
pii: S0076-6879(21)00299-8
doi: 10.1016/bs.mie.2021.06.040
pii:
doi:
Substances chimiques
Escherichia coli Proteins
0
Recombinant Proteins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105-144Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors are employed by New England Biolabs, which commercializes SHuffle cells and other enzymes, kits, and reagents.